Every year the FTC brings hundreds of cases against individuals and companies for violating consumer protection and competition laws that the agency enforces. These cases can involve fraud, scams, identity theft, false advertising, privacy violations, anti-competitive behavior and more. The Legal Library has detailed information about cases we have brought in federal court or through our internal administrative process, called an adjudicative proceeding.
Displaying 3081 - 3100 of 5959
Motorola Solutions, Inc.
Date
Matter Number
081 0028
File
Closing Letter to Counsel for Alcatel-Lucent
(126.11 KB)
File
Closing Letter to Counsel for Motorola, Inc.
(126.08 KB)
Express Consolidation, Inc., et al.
Type of Action
Federal
Last Updated
FTC Matter/File Number
052-3146
BuyExclusive.Net (Gene Kim), U.S.
Type of Action
Federal
Last Updated
FTC Matter/File Number
112 3043
Royal Tronics, Inc. d/b/a MyCandyEyes.com, and Jamil Hindi, U.S.
Type of Action
Federal
Last Updated
FTC Matter/File Number
112 3044
MyCuteLens.com (Thy Xuan Ho a/k/a Brandon Lee), U.S.
Type of Action
Federal
Last Updated
FTC Matter/File Number
112 3042
Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs
Date
By
Mary K. Engle, Associate Director
Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs
Date
By
Mary K. Engle, Associate Director
Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs
Date
By
Mary K. Engle, Associate Director
Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs
Date
By
Mary K. Engle, Associate Director
Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs
Date
By
Mary K. Engle, Associate Director
Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs
Date
By
Mary K. Engle, Associate Director
Mary K. Engle
Displaying 3081 - 3100 of 5959